Summary Deletions of tumour-suppressor genes can be detected by loss of heterozygosity (LOH) studies, which were performed on 23 cases of adenocarcinoma of the oesophagus, using 120 microsatellite prmers coverng all non-acrocentric autosomal chromosome arms.
The incidence of adenocarcinoma of the oesophagus has increased at a greater rate than anx other tumour over the last 20 X ears ( Blot et al. 1991) . and is nou the most common oesophaaeal malignancy in certain parts of the Western world (Spechler et al. 1994) . The reason for this increase is not clear. Howex er. it is knou-n that Barrett's oesophagrus. uwhich occurs in approximatelv 10% of patients w ith gastro-oesophageal reflux. is associated w ith a 30-125 times increased risk of developing adenocarcinoma (Spechler et al. 1984 : Cameron et al. 1985 : W-illiamson et al. 1991 . It is estimated that approximately 1% of patients with Barrett's oesophagrus will develop adenocarcinoma each x-ear. and this can occur up to 20 X ears after the initial diarnosis of Barrett's oesophagus (Spechler. 1987) . The histological progression durinc this period is considered to follou-metaplasia-low-grade dN splasia-high-grade dvsplasia-carcinoma (IMiros et al. 1991 ).
High-grade dy splasia (HGD) has been used as a mark-er of future cancer development. but there is interobserxer v ariation in the diagynosis of HGD (Reid et al. 1988) and not all patients with HGD A ill dexvelop cancer (Schnell et al. 1996) .
Attention has therefore focused on molecular biomarkers of carcinogenesis. Loss of function of tumour-suppressor genes resultinc from genormic insults has been implicated in the development of several different tumours. and these loss of function mutations ma!-be detected bv loss of heterozx7gosit- (LOH) studies (Ittman and W'ieczorek. 1996: Shimizu and Sakiva. 1996) . LOH studies can lead to the identification of tumour-suppressor genes that are inactix ated in the metaplasia-dxsplasia-carcinoma progression. and may therefore be useful as biomarkers of future carcinogenesis in patients w-ith Barrett's metaplasia and dx splasia undergoing endoscopic surveillance. Previous alleleotype analx ses have detected LOH in more than 40%c of oesophageal adenocarcinomas on chromosome arms lp. 4q. 5q. 9p. 13q. 17p and 18q (Barrett et al. 1996a and Hammoud et al. 1996) . These allelotype studies AWere undertak-en Awith 43 and 39 microsatellite primers respectixely. We have performed the most comprehensive genomic study of oesophageal adenocarcinoma to date. coxering all of the non-acrocentnrc chromosome arms w-ith 120 microsatellite pnrmers. enabling identification of putatiVe tumour-suppressor gene sites in oesophageal adenocarcinoma.
MATERIALS AND METHODS Patients
Twentv-three cases of adenocarcinoma of the oesophagus diagnosed betmeen 1992 and 1996 were studied. Twenty of these patients were male and their mean age xxas 68 y-ears. At present. six of these patients are alix e w ith no signs of recurrent disease.
DNA extraction
Tissue from the tumour and from normal gastric mucosa were obtained from endoscopic biopsies and from surgical resections. snapped frozen in liquid nitroaen and stored at -70 C. Areas of tumour containincg minimal stromal cells wxere microdissected and DNA extracted from the microdissected tissues usinc the Nucleon II extraction kit (Scotlab). 
Percentage LOH on each chromosomal arm
The percentage of tumours display ing LOH was calculated for each chromosomal arm (Table 1 and Firure 3). Eight chromosomal arms displayed LOH in at least 45% of the tumours: 3p (64%c). Sq (45%7c). 9p (52%7c). lip (61c,%c). 13q (50%7). 17p (96%e). 17q (55%). and 18q (70%/ ). LOH on these chromosomal arms w-as significantly greater than LOH detected on other chromosomal arms (P < 0.02. Fisher's exact test). Nineteen of 23 tumours demonstrated LOH in at least half of these chromosomal arms. Excluding the eight chromosomal arms w-ith LOH in more than 45'%-of tumours. the background LOH was 15%. xwhich is similar to that prexiously reported in oesophageal carcinoma (Wagata et al. 1991 : Huang et al. 1992 : Bovnton et al. 1992 . Allelic loss w-as detected in only one of the p or q chromosomal arms in 78%-of chromosomes. indicating that the majority of deletions represented subchromosomal events.
British Joumal of Cancer (1998) 78(7). 950-957 11i22 (50) 3/15 (20) British Journal of Cancer (1998) 78 (7), [950] [951] [952] [953] [954] [955] [956] [957] Alkelotype analysis of oesophageal adenoxarcinomas 953 D14S51  CYP19  D15S87  HBAP1  D16S303  D17S935  D17S959  TCF2  D17S261  D1 7S842  D17S58  CHRNB1  D17S953  D17S122  D17S805  D17S520  TP53  D17S740  D17S799  D17S922  D17S955  D17S839  D17S921  D17S578  D17S783  D17S798  D17S841  D17S250  THRAl  MPO  GP3A  D17S940  D17S515  AFMcOO8we  D17S801  D17S928  D18S52   D18S59  D18S43  D18S34  DCC  D18S35  D1838  D18S42  D18S70  D19S20  D19S180  D20S57  D20S120  D21S156  IL- 13q and 17p (Barrett et al. 1996a) . which is in agreement with this study (Table 2) . Although a previous studv has documented LOH on chromosome 4q in more than 50%c of oesophageal adenocarcinomas (Hammoud et al. 1996) . both our own and Barrett's allelotype study reported that fever than 20c of adenocarcinomas demonstrated LOH on 4q. We also detected significant LOH on chromosome arms 3p. 11p. 1 7q and 1 8q in our study. most probably due to the use of a greater number of microsatellite primers for each chromosomal arm in our studv. In our study. microdissection was used to minimize stromal cell contamination of the r tumour DNA. and this may also have contributed to our high LOH findings. Other investigators have used flow cytometrv to separate aneuploid cells for use in LOH studies (Barrett et al. 1996a ).
although not all oesophageal carcinomas exhibit aneuploidy on DNA analysis (Dorman et al. 1992 : Porschen et al. 1993 : Blount et al. 1994 ) and the sensitivity and specificity of the detection of aneuploidy by flow cytometry is only 79% and 60%7 respectively British Joumal of Cancer (1998) 78(7). 950-957
Allelotype analysis of oesophageal adenocarcinomas 955 (Walsh et al. 1992 ). Hence. not all oesophageal carcinomas will be amenable to this method of tumour cell procurement.
Chromosome 3 LOH on 3p has been detected in a Xariety of tumours. e.g. pulmonary (Sozzi et al. 1996) . gastrointestinal and ovanian (Chuaqui et al. 1996) . and in our study of oesophageal adenocarcinoma 64%' of tumours displayed LOH. The reaion of greatest LOH on 3p was at 3p26-p24 (primer D3S587). wxhich contains the VHL tumour-suppressor gene locus. A previous study failed to shoxx anv involvement of the VHL tumour-suppressor gene in squamous cell carcinoma of the upper aerodigestive tract (Waber et al. 1996) . but allelic loss of the VHL gene has been described in sporadic colon cancer (Zhuang et al. 1996 ) and sporadic renal cell carcinomas (Van den Berg et al. 1996) . LOH at 3p25 has been shown to be associated xxith ly mph node metastases in squamous cell carcinoma of the oesophagus (Ogasawara et al. 1995) : 7 of 13 Barrettfs adenocarcinomas displayed LOH at 3p26-p24 in this study. and six of these sexven tumours had positix e nodes. It is likely that 3p26-p24 contains a tumour-suppressor uene in olved in oesophageal carcinogenesis. but w hether it is the 1'HL tumour-suppressor gene or a nearby novel tumour-suppressor 2ene remains to be determined.
Chromosome 5 LOH on chromosome arm 5q wxas detected in 9 of 20 cases (45% ) of oesophageal adenocarcinoma. and this LOH w-as concentrated in tw o sites. One-third of tumours demonstrated LOH at 5q2 I-q2_2 (D5S346). the site of the APC tumour-suppressor gene. LOH at the APC tumour-suppressor gene has previously been described in 23 of 61 cases (38%7, ) of squamous cell carcinoma of the oesophagus (Ogasawara et al. 1996) . Howxexer. single-strand conformation polxmorphism analysis found only one APC mutation in 35 cases of oesophaaeal squamous cell carcinoma. and one APC mutation in 18 cases of oesophageal adenocarcinoma (Powell et al. 1994 (Barrett et al. 1996b) . DNA sequencing has detected mutations in the CDKN2 tumour-suppressor genes in both adenocarcinoma and squamous cell carcinoma of the oesophagus (Zhou et al. 1994 : Barrett et al. 1996b (Shibagaki et al. 1994) . LOH at I I p 15.5 has also been demonstrated in adenocarcinoma of the stomach . and candidate tumour-suppressor grenes in this regrion include 117 and HI 9. loss of w-hich have been described in 'ilms' tumours (Besnard-Guerin et al. 1996) and in cervical cancer (DoucRasy et al. 1996) respectively. This area on 1 lp obviously requires further study in oesophageal and other malignancies. (Neshat et al. 1994) . 30 of 31 (Blount et al. 1994 ) and 11 of 16 (Gleeson et al. 1995) (Kalikin et al. 1997 ).
Chromosome 18
The DCC tumour-suppressor cene is most commonlv inactivated in carcinoma of the colon (Fearon et al. 1990 ). In our study. LOH at the DCC locus was detected in 4 of 13 (31%) oesophageal adenocarcinomas. which is similar to the 29%c detected prexiously (Huanget al. 1992 ).
FAL and genomic instability (Vogelstein et al. 1989 ). head and neck (FAL of 0.22) (Field et al. 1995) and non-small-cell luna cancer (FAL of 0.09) (Neville et al. 1996) . but is similar to a FAL of 0.28 calculated for 20 cases of oesophageal adenocarcinoma (Barrett et al. 1996a 
